ES2151383B1 - Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente. - Google Patents

Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente.

Info

Publication number
ES2151383B1
ES2151383B1 ES009800585A ES9800585A ES2151383B1 ES 2151383 B1 ES2151383 B1 ES 2151383B1 ES 009800585 A ES009800585 A ES 009800585A ES 9800585 A ES9800585 A ES 9800585A ES 2151383 B1 ES2151383 B1 ES 2151383B1
Authority
ES
Spain
Prior art keywords
antialergic
hydroquinone
agent
salts
hydrocloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES009800585A
Other languages
English (en)
Other versions
ES2151383A1 (es
Inventor
Toshio Satoh
Tetsuo Ebata
Yasuo Kosaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTT Institute Co Ltd
Kuree Co Ltd
Original Assignee
LTT Institute Co Ltd
Kuree Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTT Institute Co Ltd, Kuree Co Ltd filed Critical LTT Institute Co Ltd
Publication of ES2151383A1 publication Critical patent/ES2151383A1/es
Application granted granted Critical
Publication of ES2151383B1 publication Critical patent/ES2151383B1/es
Anticipated expiration legal-status Critical
Withdrawn - After Issue legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Derivado de hidroquinona, sus sales de hidrocloruro, agente antialérgico que lo comprende y fármaco antialérgico correspondiente; el agente antialérgico que tiene una acción inhibitorio sobre la producción de leucotrieno y una acción antihistamínica, que puede administrarse por vía oral; el agente antialérgico comprende un derivado de hidroquinona de fórmula general en la que n representa un número entero de 2 a 10.
ES009800585A 1997-03-21 1998-03-18 Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente. Withdrawn - After Issue ES2151383B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9085558A JPH10265386A (ja) 1997-03-21 1997-03-21 抗酸化作用を有する抗アレルギー剤

Publications (2)

Publication Number Publication Date
ES2151383A1 ES2151383A1 (es) 2000-12-16
ES2151383B1 true ES2151383B1 (es) 2001-07-01

Family

ID=13862156

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009800585A Withdrawn - After Issue ES2151383B1 (es) 1997-03-21 1998-03-18 Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente.

Country Status (10)

Country Link
US (1) US5910499A (es)
JP (1) JPH10265386A (es)
KR (1) KR100258638B1 (es)
CN (1) CN1201791A (es)
CA (1) CA2232787A1 (es)
DE (1) DE19811620A1 (es)
ES (1) ES2151383B1 (es)
FR (1) FR2761062A1 (es)
GB (1) GB2323358B (es)
IT (1) IT1298771B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
FR1212015A (fr) * 1957-03-27 1960-03-21 Union Chimique Belge Sa Nouveaux dérivés de la nu-mono-benzhydryl-pipérazine et leur procédé de préparation
FR2584402B2 (fr) * 1985-07-04 1987-10-09 Cortial Nouveaux derives d'(arylpiperazinylethylaminoethoxy)-4 phenols, leur methode de preparation et leur application therapeutique
EP0173634B1 (fr) * 1984-08-07 1988-08-31 Cortial S.A. Nouveaux dérivés d'(arylpipérazinyléthylaminoéthoxy)-4 phénol, leur méthode de préparation et leur application thérapeutique
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5432179A (en) * 1991-07-19 1995-07-11 Zeria Pharmaceutical Co., Ltd. Piperazine derivatives and pharmaceuticals containing the same
FR2681324B1 (fr) * 1991-09-18 1993-10-29 Adir Cie Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
AUPN977296A0 (en) * 1996-05-10 1996-06-06 Monash University Pharmaceutical agents

Also Published As

Publication number Publication date
US5910499A (en) 1999-06-08
GB2323358B (en) 2000-10-25
ITMI980575A1 (it) 1999-09-20
KR100258638B1 (ko) 2000-07-01
FR2761062A1 (fr) 1998-09-25
KR19980080495A (ko) 1998-11-25
DE19811620A1 (de) 1998-09-24
IT1298771B1 (it) 2000-02-02
GB2323358A (en) 1998-09-23
JPH10265386A (ja) 1998-10-06
CA2232787A1 (en) 1998-09-21
GB9805642D0 (en) 1998-05-13
CN1201791A (zh) 1998-12-16
ES2151383A1 (es) 2000-12-16

Similar Documents

Publication Publication Date Title
CO5160286A1 (es) Composiciones farmaceuticas ne orlistat y quitosan
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ES2157881T3 (es) Metanosulfonato de paroxetina.
AR033796A1 (es) Composicion farmaceutica
BR0012901A (pt) Medicamentos de ß - carbolina
CY1107861T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τερβιναφινη και η χρηση τους
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
AR018828A1 (es) Formulaciones efervescentes solidas de rapida desintegracion para administracion oral.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
UY27644A1 (es) Sistema de suministro osmótico
AR036689A1 (es) La forma pseudopolimorfica de (+/-) 1-(4-carbazoliloxi)-3-[2-(2-metoxifenoxi) etilamino]-2-propanol o formas opticamente activas o sales farmaceuticamente aceptables de la misma, uso de la misma, una composicion farmaceuticamente aceptable que la comprende, una forma de administracion farmaceuticame
ES2151383B1 (es) Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
PT1259261E (pt) Composicoes farmaceuticas que compreendem terbinafina
AR024981A1 (es) Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon
AR042037A1 (es) Profarmaco de celecoxib
ATE395049T1 (de) Verbesserte pharmazeutische zusammensetzungen von hiv-proteasehemmern
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
NO20044519L (no) Hyperforinderivater, anvendelse derav samt formuleringer som inneholder dem
ECSP003602A (es) PRODUCTOS DE LA DROGA ß- CARBOLINE

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20001216

Kind code of ref document: A1

Effective date: 20001216

FA2A Application withdrawn

Effective date: 20031120